Implications of Clinical Trial Design on Sample Size Requirements

Journal Title: Schizophrenia Bulletin - Year , Vol 34, Issue 4

Abstract

The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison groups reduce the risk of bias. The design must also provide sufficient statistical power to detect a clinically meaningful treatment effect and maintain a nominal level of type I error. An attempt to integrate neurocognitive science into an RCT poses additional challenges. Two particularly relevant aspects of such a design often receive insufficient attention in an RCT. Multiple outcomes inflate type I error, and an unreliable assessment process introduces bias and reduces statistical power. Here we describe how both unreliability and multiple outcomes can increase the study costs and duration and reduce the feasibility of the study. The objective of this article is to consider strategies that overcome the problems of unreliability and multiplicity.

Authors and Affiliations

Andrew C. Leon

Keywords

Related Articles

An Investigation of the Relationship Between Activation of a Social Cognitive Neural Network and Social Functioning

Previous work examining the neurobiological substrates of social cognition in healthy individuals has reported modulation of a social cognitive network such that increased activation of the amygdala, fusiform gyrus, and...

Implications of Clinical Trial Design on Sample Size Requirements

The primary goal in designing a randomized controlled clinical trial (RCT) is to minimize bias in the estimate of treatment effect. Randomized group assignment, double-blinded assessments, and control or comparison group...

Schizophrenia, Psychiatric Genetics, and Darwinian Psychiatry: An Evolutionary Framework

The evolutionary origins of one of the most dramatic and seemingly deleterious behavioral phenotypes, the syndrome known as schizophrenia, are mysterious. Schizophrenia occurs in all cultures and is inherited. Although m...

Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder

Twin studies show that the concordance rate for schizophrenia is higher in monozygotic twins (47%–56%) than in dizygotic twins (12%–16%), suggesting a strong heritability component for the illness. Some s...

Neurophysiological Endophenotypes Across Bipolar and Schizophrenia Psychosis

The search for liability genes of the world's 2 major psychotic disorders, schizophrenia and bipolar disorder I (BP-I), has been extremely difficult even though evidence suggests that both are highly heritable. This diff...

Download PDF file
  • EP ID EP683278
  • DOI  10.1093/schbul/sbn035
  • Views 91
  • Downloads 0

How To Cite

Andrew C. Leon (). Implications of Clinical Trial Design on Sample Size Requirements. Schizophrenia Bulletin, 34(4), -. https://europub.co.uk./articles/-A-683278